Inozyme Pharma(INZY)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

INZY Inozyme Pharma

休市中 12-20 16:00:00 EST

2.99

+0.18

+6.41%

盘后3.05

+0.06+2.01%

17:34 EST

最高3.02	最低2.77	成交量93.22万
今开2.77	昨收2.81	日振幅8.90%
总市值1.92亿	流通市值1.18亿	总股本6,424万
成交额274.66万	换手率2.37%	流通股本3,938万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"INZY","market":"US","secType":"STK","nameCN":"Inozyme Pharma","latestPrice":2.99,"timestamp":1734728400000,"preClose":2.81,"halted":0,"volume":932240,"hourTrading":{"tag":"盘后","latestPrice":3.05,"preClose":2.99,"latestTime":"17:34 EST","volume":33615,"amount":100600.845,"timestamp":1734734046695},"delay":0,"floatShares":39380500,"shares":64240198,"eps":-1.550867,"marketStatus":"休市中","marketStatusCode":7,"change":0.18,"latestTime":"12-20 16:00:00 EST","open":2.77,"high":3.02,"low":2.77,"amount":2746623.659776,"amplitude":0.088968,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.550867,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1734944400000},"adr":0,"listingDate":1595563200000,"adjPreClose":2.81,"preHourTrading":{"tag":"盘前","latestPrice":2.78,"preClose":2.81,"latestTime":"09:29 EST","volume":768,"amount":2143.830144,"timestamp":1734704970097},"postHourTrading":{"tag":"盘后","latestPrice":3.05,"preClose":2.99,"latestTime":"17:34 EST","volume":33615,"amount":100600.845,"timestamp":1734734046695},"volumeRatio":1.5463874769429917,"impliedVol":1.2229,"impliedVolPercentile":0.4484},"requestUrl":"/m/hq/s/INZY","defaultTab":"news","newsList":[{"id":"2493742674","title":"Inozyme Pharma, Inc.盘中异动 临近午盘股价大涨5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2493742674","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493742674?lang=zh_cn&edition=full","pubTime":"2024-12-21 00:39","pubTimestamp":1734712785,"startTime":"0","endTime":"0","summary":"北京时间2024年12月21日00时39分，Inozyme Pharma, Inc.股票出现波动，股价急速上涨5.30%。Inozyme Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.32%。Inozyme Pharma, Inc.公司简介：Inozyme Pharma 是一家临床阶段的罕见病生物制药公司，致力于开发用于治疗影响血管、软组织和骨骼疾病的新型治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241221003945984cfe81&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241221003945984cfe81&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","INZY"],"gpt_icon":0},{"id":"2492399881","title":"Inozyme Pharma, Inc.盘中异动 急速下跌5.30%报2.86美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492399881","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492399881?lang=zh_cn&edition=full","pubTime":"2024-12-18 01:05","pubTimestamp":1734455152,"startTime":"0","endTime":"0","summary":"北京时间2024年12月18日01时05分，Inozyme Pharma, Inc.股票出现波动，股价大幅跳水5.30%。Inozyme Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.75%。Inozyme Pharma, Inc.公司简介：Inozyme Pharma 是一家临床阶段的罕见病生物制药公司，致力于开发用于治疗影响血管、软组织和骨骼疾病的新型治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218010553984c92b6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218010553984c92b6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","INZY"],"gpt_icon":0},{"id":"2491371696","title":"Inozyme Pharma, Inc.盘中异动 急速跳水5.37%报2.82美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2491371696","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491371696?lang=zh_cn&edition=full","pubTime":"2024-12-13 23:16","pubTimestamp":1734102980,"startTime":"0","endTime":"0","summary":"北京时间2024年12月13日23时16分，Inozyme Pharma, Inc.股票出现波动，股价急速下跌5.37%。Inozyme Pharma, Inc.股票所在的生物技术行业中，整体跌幅为0.22%。Inozyme Pharma, Inc.公司简介：Inozyme Pharma 是一家临床阶段的罕见病生物制药公司，致力于开发用于治疗影响血管、软组织和骨骼疾病的新型治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121323162195e978f1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121323162195e978f1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INZY","BK4139"],"gpt_icon":0},{"id":"2490055381","title":"Inozyme Pharma, Inc.盘中异动 早盘股价大涨6.08%报3.14美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490055381","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490055381?lang=zh_cn&edition=full","pubTime":"2024-12-12 22:30","pubTimestamp":1734013825,"startTime":"0","endTime":"0","summary":"北京时间2024年12月12日22时30分，Inozyme Pharma, Inc.股票出现波动，股价急速上涨6.08%。Inozyme Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Palisade Bio, Inc.、Trevi Therapeutics, Inc.、Conduit Pharmaceuticals Inc.涨幅较大，Palisade Bio, Inc.、Aptevo Therapeutics Inc.、Conduit Pharmaceuticals Inc.较为活跃，换手率分别为1811.46%、395.93%、48.75%，振幅较大的相关个股有Os Therapies Incorporated、Pluri Inc.、Actinium Pharmaceuticals, Inc. ，振幅分别为10.63%、4.56%、3.13%。Inozyme Pharma, Inc.公司简介：Inozyme Pharma 是一家临床阶段的罕见病生物制药公司，致力于开发用于治疗影响血管、软组织和骨骼疾病的新型治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212223025984b965d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212223025984b965d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","INZY"],"gpt_icon":0},{"id":"2490863974","title":"Inozyme Pharma, Inc.盘中异动 股价大跌5.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490863974","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490863974?lang=zh_cn&edition=full","pubTime":"2024-12-11 22:33","pubTimestamp":1733927593,"startTime":"0","endTime":"0","summary":"北京时间2024年12月11日22时33分，Inozyme Pharma, Inc.股票出现波动，股价急速下挫5.37%。Inozyme Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.10%。Inozyme Pharma, Inc.公司简介：Inozyme Pharma 是一家临床阶段的罕见病生物制药公司，致力于开发用于治疗影响血管、软组织和骨骼疾病的新型治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211223313a1e66b92&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211223313a1e66b92&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INZY","BK4139"],"gpt_icon":0},{"id":"2490199960","title":"Inozyme Pharma, Inc.盘中异动 急速拉升5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490199960","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490199960?lang=zh_cn&edition=full","pubTime":"2024-12-10 22:32","pubTimestamp":1733841166,"startTime":"0","endTime":"0","summary":"北京时间2024年12月10日22时32分，Inozyme Pharma, Inc.股票出现波动，股价急速上涨5.07%。Inozyme Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.01%。Inozyme Pharma, Inc.公司简介：Inozyme Pharma 是一家临床阶段的罕见病生物制药公司，致力于开发用于治疗影响血管、软组织和骨骼疾病的新型治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121022324695e8ae20&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121022324695e8ae20&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","INZY"],"gpt_icon":0},{"id":"2489583512","title":"Inozyme Pharma, Inc.盘中异动 早盘股价大涨5.24%报2.61美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2489583512","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489583512?lang=zh_cn&edition=full","pubTime":"2024-12-06 23:47","pubTimestamp":1733500072,"startTime":"0","endTime":"0","summary":"北京时间2024年12月06日23时47分，Inozyme Pharma, Inc.股票出现波动，股价快速拉升5.24%。Inozyme Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.70%。Inozyme Pharma, Inc.公司简介：Inozyme Pharma 是一家临床阶段的罕见病生物制药公司，致力于开发用于治疗影响血管、软组织和骨骼疾病的新型治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206234752971c2841&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206234752971c2841&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INZY","BK4139"],"gpt_icon":0},{"id":"2489465089","title":"Inozyme Pharma, Inc.盘中异动 早盘股价大跌5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2489465089","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489465089?lang=zh_cn&edition=full","pubTime":"2024-12-05 23:40","pubTimestamp":1733413211,"startTime":"0","endTime":"0","summary":"北京时间2024年12月05日23时40分，Inozyme Pharma, Inc.股票出现异动，股价急速下跌5.02%。Inozyme Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.36%。Inozyme Pharma, Inc.公司简介：Inozyme Pharma 是一家临床阶段的罕见病生物制药公司，致力于开发用于治疗影响血管、软组织和骨骼疾病的新型治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205234011ab601f68&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205234011ab601f68&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INZY","BK4139"],"gpt_icon":0},{"id":"2488081606","title":"Inozyme Pharma, Inc.盘中异动 股价大跌5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2488081606","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488081606?lang=zh_cn&edition=full","pubTime":"2024-12-02 23:39","pubTimestamp":1733153979,"startTime":"0","endTime":"0","summary":"北京时间2024年12月02日23时39分，Inozyme Pharma, Inc.股票出现异动，股价快速下跌5.17%。Inozyme Pharma, Inc.股票所在的生物技术行业中，整体跌幅为0.12%。Inozyme Pharma, Inc.公司简介：Inozyme Pharma 是一家临床阶段的罕见病生物制药公司，致力于开发用于治疗影响血管、软组织和骨骼疾病的新型治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202233939abf0249d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202233939abf0249d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","INZY"],"gpt_icon":0},{"id":"2486507900","title":"Inozyme Pharma, Inc.盘中异动 临近收盘急速下挫5.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486507900","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486507900?lang=zh_cn&edition=full","pubTime":"2024-11-26 04:56","pubTimestamp":1732568182,"startTime":"0","endTime":"0","summary":"北京时间2024年11月26日04时56分，Inozyme Pharma, Inc.股票出现波动，股价急速下跌5.34%。Inozyme Pharma, Inc.股票所在的生物技术行业中，整体涨幅为1.59%。Inozyme Pharma, Inc.公司简介：Inozyme Pharma 是一家临床阶段的罕见病生物制药公司，致力于开发用于治疗影响血管、软组织和骨骼疾病的新型治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126045622abde9f75&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126045622abde9f75&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INZY","BK4139"],"gpt_icon":0},{"id":"2485213007","title":"Inozyme Pharma, Inc.盘中异动 下午盘股价大涨5.20%报2.83美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485213007","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485213007?lang=zh_cn&edition=full","pubTime":"2024-11-23 03:39","pubTimestamp":1732304398,"startTime":"0","endTime":"0","summary":"北京时间2024年11月23日03时39分，Inozyme Pharma, Inc.股票出现异动，股价急速拉升5.20%。Inozyme Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.52%。Inozyme Pharma, Inc.公司简介：Inozyme Pharma 是一家临床阶段的罕见病生物制药公司，致力于开发用于治疗影响血管、软组织和骨骼疾病的新型治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123033959abd80c7f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123033959abd80c7f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","INZY"],"gpt_icon":0},{"id":"2484602632","title":"Inozyme Pharma, Inc.盘中异动 下午盘快速跳水5.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484602632","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484602632?lang=zh_cn&edition=full","pubTime":"2024-11-19 02:38","pubTimestamp":1731955094,"startTime":"0","endTime":"0","summary":"北京时间2024年11月19日02时38分，Inozyme Pharma, Inc.股票出现波动，股价大幅跳水5.44%。Inozyme Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.05%。Inozyme Pharma, Inc.公司简介：Inozyme Pharma 是一家临床阶段的罕见病生物制药公司，致力于开发用于治疗影响血管、软组织和骨骼疾病的新型治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119023814971a7408&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119023814971a7408&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","INZY"],"gpt_icon":0},{"id":"2483515478","title":"Inozyme Pharma, Inc.盘中异动 股价大跌5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483515478","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483515478?lang=zh_cn&edition=full","pubTime":"2024-11-14 03:43","pubTimestamp":1731526982,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日03时43分，Inozyme Pharma, Inc.股票出现异动，股价大幅下挫5.05%。Inozyme Pharma, Inc.股票所在的生物技术行业中，整体跌幅为0.44%。Inozyme Pharma, Inc.公司简介：Inozyme Pharma 是一家临床阶段的罕见病生物制药公司，致力于开发用于治疗影响血管、软组织和骨骼疾病的新型治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111403430398e42730&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111403430398e42730&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","INZY"],"gpt_icon":0},{"id":"2482678702","title":"Inozyme Pharma, Inc.2024财年第三财季实现净利润-24.57百万美元，同比减少47.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482678702","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482678702?lang=zh_cn&edition=full","pubTime":"2024-11-11 00:00","pubTimestamp":1731254425,"startTime":"0","endTime":"0","summary":"11月11日，Inozyme Pharma, Inc.公布财报，公告显示公司2024财年第三财季净利润为-24.57百万美元，同比减少47.66%；其中营业收入为0.00美元，每股基本收益为-0.39美元。从资产负债表来看，Inozyme Pharma, Inc.总负债60.57百万美元，其中短期债务4.56百万美元，资产负债比为0.03，流动比率为0.08。机构评级：截至2024年11月11日，当前有8家机构对Inozyme Pharma, Inc.目标价做出预测，其中目标均价为18.75美元，其中最低目标价为12.00美元，最高目标价为43.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111000033abb3620d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111000033abb3620d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INZY"],"gpt_icon":0},{"id":"2481624519","title":"美国研究综述-阿波罗、Booking Holdings、Portillos","url":"https://stock-news.laohu8.com/highlight/detail?id=2481624519","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481624519?lang=zh_cn&edition=full","pubTime":"2024-11-06 17:15","pubTimestamp":1730884501,"startTime":"0","endTime":"0","summary":"    路透11月6日 - 华尔街证券分析师周三调整了对几家美国上市公司的评级和目标价，其中包括阿波罗、Booking Holdings 和 Portillos。要闻 * 阿波罗  ：摩根大通将目标价从143美元上调至161美元 * Aris Water Solutions Inc   ：摩根大通将其评级从 \"增持 \"下调至 \"中性  * Booking Holdings Inc   ：Truist Securities将目标价从4100美元上调至4700美元  * Choice Hotels International Inc   ：杰富瑞将其评级从 \"买入 \"下调至 \"持有  * Portillos Inc   ：Stifel将其评级从 \"买入 \"下调至 \"持有  以下是路透周三报道的美国公司研究报告摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BRKR","AMH","BK4113","LU2065169927.USD","AGCO","GFS","LU0426417589.USD","MO","APO","ABBV","FRPT","BKNG","CC","FIS","GMED","APLS","AHCO","BVS","GO","LU2065171311.SGD","EMN","HPK","LU0868494708.USD","CTRE","EMR","ADUS","CHH","ARIS","CE","BLDR","BEAM","AIG","BK4141","AVB","IT","AZPN","ABNB","INZY","CMI","ACLX","LU0390134368.USD","LU0708994859.HKD","ANAB","BR","DBRG","EXAS","BOW","LU0029874061.USD","ALL","GXO"],"gpt_icon":0},{"id":"2481761403","title":"Inozyme Pharma Inc 报告截至 9 月 30 日的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2481761403","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481761403?lang=zh_cn&edition=full","pubTime":"2024-11-06 12:58","pubTimestamp":1730869088,"startTime":"0","endTime":"0","summary":"   * Inozyme Pharma Inc   报告，截至9月30日的季度调整后每股亏损39美分，低于去年同期的每股收益-29美分。九位分析师对该季度的平均预期是每股亏损 44 美分。华尔街预期为每股-46美分至-41美分。* Inozyme Pharma Inc 公布的季度每股收益为亏损 39 美分。* Inozyme Pharma Inc 本季度股价下跌了 15.5%，今年迄今为止上涨了 3.8%。华尔街对 Inozyme Pharma Inc 的 12 个月目标价中位数为 15.00 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Inozyme Pharma Inc 报告截至 9 月 30 日的季度业绩 - 收益摘要","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INZY","BK4139"],"gpt_icon":0},{"id":"2480581506","title":"Inozyme Pharma, Inc.盘中异动 早盘股价大涨8.75%报4.74美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480581506","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480581506?lang=zh_cn&edition=full","pubTime":"2024-11-04 22:31","pubTimestamp":1730730689,"startTime":"0","endTime":"0","summary":"北京时间2024年11月04日22时31分，Inozyme Pharma, Inc.股票出现异动，股价快速拉升8.75%。Inozyme Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.14%。Inozyme Pharma, Inc.公司简介：Inozyme Pharma 是一家临床阶段的罕见病生物制药公司，致力于开发用于治疗影响血管、软组织和骨骼疾病的新型治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104223133a215492e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104223133a215492e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INZY","BK4139"],"gpt_icon":0},{"id":"2480805448","title":"Inozyme Pharma Inc   预计每股亏损44美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2480805448","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480805448?lang=zh_cn&edition=full","pubTime":"2024-11-01 22:52","pubTimestamp":1730472759,"startTime":"0","endTime":"0","summary":"   * Inozyme Pharma Inc    预计在11月5日公布截至2024年9月30日的业绩时，季度收入将没有变化(预计)。*    * LSEG分析师对Inozyme Pharma Inc的平均预期是每股亏损44美分。* 目前，分析师对该公司股票的平均评级为 \"买入\"，建议分类为 9 个 \"强烈买入 \"或 \"买入\"，没有 \"持有\"，也没有 \"卖出 \"或 \"强烈卖出\"。* 华尔街对 Inozyme Pharma Inc 的 12 个月目标价中位数为 15.50 美元，高于其最新收盘价 4.29 美元。11月1日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Inozyme Pharma Inc   预计每股亏损44美分 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INZY"],"gpt_icon":0},{"id":"2480066134","title":"Inozyme Pharma, Inc.盘中异动 大幅下挫5.07%报4.31美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480066134","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480066134?lang=zh_cn&edition=full","pubTime":"2024-11-01 03:55","pubTimestamp":1730404526,"startTime":"0","endTime":"0","summary":"北京时间2024年11月01日03时55分，Inozyme Pharma, Inc.股票出现异动，股价大幅下跌5.07%。Inozyme Pharma, Inc.股票所在的生物技术行业中，整体跌幅为3.00%。Inozyme Pharma, Inc.公司简介：Inozyme Pharma 是一家临床阶段的罕见病生物制药公司，致力于开发用于治疗影响血管、软组织和骨骼疾病的新型治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101035526ab8d3801&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101035526ab8d3801&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","INZY"],"gpt_icon":0},{"id":"2479236765","title":"Inozyme Pharma, Inc.盘中异动 大幅下挫5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479236765","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479236765?lang=zh_cn&edition=full","pubTime":"2024-10-30 00:26","pubTimestamp":1730219210,"startTime":"0","endTime":"0","summary":"北京时间2024年10月30日00时26分，Inozyme Pharma, Inc.股票出现波动，股价急速下跌5.23%。Inozyme Pharma, Inc.股票所在的生物技术行业中，整体跌幅为0.13%。Inozyme Pharma, Inc.公司简介：Inozyme Pharma 是一家临床阶段的罕见病生物制药公司，致力于开发用于治疗影响血管、软组织和骨骼疾病的新型治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103000265098e3f273&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103000265098e3f273&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","INZY"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.inozyme.com","stockEarnings":[{"period":"1week","weight":-0.0132},{"period":"1month","weight":0.0717},{"period":"3month","weight":-0.4782},{"period":"6month","weight":-0.3281},{"period":"1year","weight":-0.2654},{"period":"ytd","weight":-0.2981}],"compareEarnings":[{"period":"1week","weight":-0.0221},{"period":"1month","weight":0.0006},{"period":"3month","weight":0.0397},{"period":"6month","weight":0.0851},{"period":"1year","weight":0.2499},{"period":"ytd","weight":0.243}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Inozyme Pharma, Inc.根据特拉华州法律成立于2015年9月。该公司是一家罕见的疾病生物制药公司，致力于开发新颖的疗法来治疗影响血管，软组织和骨骼的异常矿化疾病。通过对矿化所涉及的生物途径的深入了解，该公司致力于开发治疗剂以解决这些使人衰弱的疾病的根本原因。","yearOnYearQuotes":[{"month":1,"riseRate":0.75,"avgChangeRate":0.398674},{"month":2,"riseRate":0.5,"avgChangeRate":0.035032},{"month":3,"riseRate":0.5,"avgChangeRate":0.231994},{"month":4,"riseRate":0,"avgChangeRate":-0.140893},{"month":5,"riseRate":0.5,"avgChangeRate":-0.000114},{"month":6,"riseRate":0.5,"avgChangeRate":0.047361},{"month":7,"riseRate":0.25,"avgChangeRate":-0.006548},{"month":8,"riseRate":0.2,"avgChangeRate":0.036393},{"month":9,"riseRate":0,"avgChangeRate":-0.135388},{"month":10,"riseRate":0,"avgChangeRate":-0.227258},{"month":11,"riseRate":0.4,"avgChangeRate":-0.05305},{"month":12,"riseRate":0.4,"avgChangeRate":-0.082774}],"exchange":"NASDAQ","name":"Inozyme Pharma","nameEN":"Inozyme Pharma"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Inozyme Pharma(INZY)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Inozyme Pharma(INZY)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Inozyme Pharma,INZY,Inozyme Pharma股票,Inozyme Pharma股票老虎,Inozyme Pharma股票老虎国际,Inozyme Pharma行情,Inozyme Pharma股票行情,Inozyme Pharma股价,Inozyme Pharma股市,Inozyme Pharma股票价格,Inozyme Pharma股票交易,Inozyme Pharma股票购买,Inozyme Pharma股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Inozyme Pharma(INZY)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Inozyme Pharma(INZY)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}